These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
414 related items for PubMed ID: 18082106
1. [Are there substantial reasons for contraindicating antidepressants in bipolar disorder? Part III. The alternatives!]. Hausmann A, Fuchs M, Walpoth M, Hörtnagl C, Adami P, Conca A. Neuropsychiatr; 2007; 21(4):248-60. PubMed ID: 18082106 [Abstract] [Full Text] [Related]
2. Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review. Möller HJ, Grunze H, Broich K. Eur Arch Psychiatry Clin Neurosci; 2006 Feb; 256(1):1-16. PubMed ID: 16078087 [Abstract] [Full Text] [Related]
3. [Are there substantial reasons for contraindicating antidepressants in bipolar disorder? Part II: facts or artefacts?]. Hausmann A, Hörtnagl C, Walpoth M, Fuchs M, Conca A. Neuropsychiatr; 2007 Feb; 21(2):131-58. PubMed ID: 17640499 [Abstract] [Full Text] [Related]
6. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. Sidor MM, Macqueen GM. J Clin Psychiatry; 2011 Feb; 72(2):156-67. PubMed ID: 21034686 [Abstract] [Full Text] [Related]
7. An analysis of the efficacy of treatments for bipolar depression. Nierenberg AA. J Clin Psychiatry; 2008 Feb; 69 Suppl 5():4-8. PubMed ID: 19265634 [Abstract] [Full Text] [Related]
8. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. Solmi M, Veronese N, Zaninotto L, van der Loos ML, Gao K, Schaffer A, Reis C, Normann C, Anghelescu IG, Correll CU. CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028 [Abstract] [Full Text] [Related]